Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,600.00
Bid: 1,598.00
Ask: 1,598.50
Change: -4.50 (-0.28%)
Spread: 0.50 (0.031%)
Open: 1,613.00
High: 1,613.00
Low: 1,589.00
Prev. Close: 1,604.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Hargreaves Lansdown Hit After Profit Drop

Wed, 04th Feb 2015 11:40

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 WINNERS
-------
Sky, up 1.9%. The company posted a big increase in pretax profit for the first half of its financial year, boosted by a rise in revenue and exceptional gains from the sale of its stakes in ITV PLC and the National Geographic Channel. Profit was boosted by a GBP492 million gain from the sale of its 6.4% stake in ITV PLC and a GBP296 million gain from the sale of its stake in the National Geographic Channel.

Arm Holdings, up 1.6%. The chip designer announced a new suite of intellectual properties that are expected to be launched on mobile devices in 2016, including its ARM Cortex-A72 processor. The group said that in target configurations, the new processor well deliver CPU performance that is 50 times that of leading smartphones from five years ago.

Antofagasta, up 1%, Rio Tinto, up 0.4%, Glencore, up 0.4%, Fresnillo, up 1.3%, and Randgold Resources, up 0.5%, Mining shares are up after China's central bank lowered its banks' reserve requirement ratio by 0.5 percentage points in order to support lending. The gold miners are  getting a boost from a rise in the gold price to USD1,268.86.

GlaxoSmithKline, up 0.3%. Sky News reported that it has learnt that Glaxo has hired Citi, Goldman Sachs and Morgan Stanley as financial advisers on its HIV medicines joint venture ViiV Healthcare. It says the appointment of the banks will fuel the prospect of Glaxo floating the division, which analysts believe could be worth at least GBP17 billion. The shares are up ahead of the company's full year results at 1200 GMT.
-------
FTSE 100 LOSERS
-------
Hargreaves Lansdown, down 5.7%. The investment management product provider reported a drop in first-half pretax profit, despite a rise in assets under administration over the course of the six months, in what was described as a "muted" time for stocks and retail investors. The group said pretax profit declined to GBP101.9 million in the six months ended December 31 from GBP104.1 million in the corresponding period last year.

Tullow Oil, down 3.9%, BP, down 1.5% and Weir Group, down 1.4%. A drop in oil prices is dragging down oil-related stocks. Brent currently trades at USD56.44 a barrel. Moreover, Royal Dutch Shell B, down 1.9%, and Royal Shell A, down 1.5%, has suffered price target cuts. Liberum has cut the oil major price target to 2,120p from 2,230p, keeping its rating at Hold, while LBBW has cut the company's price target price target to 2,450p from 2,600p, keeping its rating at Buy.
-------
FTSE 250 WINNERS
-------
BTG, up 1.4%. Panmure has raised the Healthcare company's price target to 1,305p from 800p, keeping its rating at Buy.
-------
FTSE 250 LOSERS
-------
Afren, down 7.5% and Premier Oil, down 2.5%. Both oil-related stocks are suffering from the fall in oil prices.

Moneysupermarket.com Group, down 3.9%. Numis said the stock is overvalued against its online listed peers, based on numerous metrics, and the broker would be downbeat on the company at its current share price even without the potential threat posed by Google
-------
AIM ALL-SHARE WINNERS
-------
Camkids Group, up 38%. The China-based children's clothing company shares are up, even though it said it expects its results for the year to miss market expectations after a number of orders were cancelled in December, exacerbating existing problems the company was facing from the weaker economic environment in China. Following that warning, certain distributors for Camkids requested the postponement or cancellation of some orders totalling CNY79 million. The company said it thought its shares were being undervalued.

Dillistone Group, up 19%. Recruitment software supplier said it expects its full year results for 2014, excluding acquisition related items, will be at a similar level to 2013, and said it enters 2015 with a stronger pipeline. The company said order intake in its Systems Division rose more than 20% in the fourth quarter of 2014. It said it had won more new business contracts in December than it had in any month of the last two years.

Nostra Terra Oil and Gas Co, up 8.7%. The company said it placed four new wells into production during the fourth quarter which significantly increased production and said although its partners are cutting back on drilling activity, it will take advantage of the low oil price to try and secure further growth opportunities.

Mosman Oil and Gas, up 6.9%. The group said it has started flow testing on the Crossroads-1 well at its Petroleum Creek project in New Zealand and it has now received the technical report on the cores and cuttings from the 2014 drilling programme at Crestal-1 and Crestal-2.
-------
AIM ALL-SHARE LOSERS
-------
Craven House Capital, off 8%. Investment company said that talks over a potential investment have ended, after it had confirmed last month that talks were ongoing. "The company confirms that these discussions have been terminated," Craven House Capital said.
-------

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.